Etoposide encapsulated in positively charged liposomes: pharmacokinetic studies in mice and formulation stability studies

This publication has 15 references indexed in Scilit:

• Evaluation of the Antitumour Activity of Liposomal Formulations of Etoposide Against Choriocarcinoma Xenografts in Balb/c nu/nu Mice
  Pharmacy and Pharmacology Communications, 1999
• Therapy of a xenografted human colonic carcinoma using cisplatin or doxorubicin encapsulated in long-circulating pegylated stealth liposomes
  International Journal of Cancer, 1999
• Etoposide: four decades of development of a topoisomerase II inhibitor
  European Journal Of Cancer, 1998
• Prophylaxis and therapy of mouse mammary carcinomas with doxorubicin and vincristine encapsulated in sterically stabilised liposomes
  European Journal Of Cancer, 1995
• A phase II study of oral etoposide in elderly patients with small cell lung cancer.
  Thorax, 1989
• Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide
  New England Journal of Medicine, 1987
• Quantification of teniposide in human serum by high-performance liquid chromatography with electrochemical detection
  Journal of Chromatography B: Biomedical Sciences and Applications, 1986
• Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour model
  British Journal of Cancer, 1985
• Etoposide: A Semisynthetic Epipodophyllotoxin Chemistry, Pharmacology, Pharmacokinetics, Adverse Effects and Use as an Antineoplastic Agent
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1984
• Studies on the mechanism of membrane fusion: kinetics of calcium ion induced fusion of phosphatidylserine vesicles followed by a new assay for mixing of aqueous vesicle contents
  Biochemistry, 1980